Locus Biosciences Partners with Viatris to Develop Precision Antibacterial Therapies for Ophthalmic Infections

Locus Biosciences has entered a research collaboration with Viatris to develop precision antibacterial therapeutics for ophthalmic infections. Locus's proprietary platform integrates AI, robotics, and synthetic biology to create bacteriophage cocktails that selectively eliminate pathogenic bacteria while sparing beneficial species. The collaboration aims to address the growing burden of antimicrobial resistance in eye infections.